Silver Nano – A Trove for Retinal Therapies
Silver nanoparticles are being discovered to have profound therapeutic properties in certain diseases of the eyes that can result in visual impairment or even irreversible blindness. This clinical study review shows that silver nanoparticles may play a successful role in reversing pathological retinal angiogenesis (neovascularization), one of the most feared complications among retinal diseases.
According to the study authors, “Recent findings made by us on therapeutic applications of biologically synthesized silver nanoparticles (AgNPs) against VEGF induced retinal endothelial cells, elucidates the effectual inhibitory activities of AgNPs over the downstream signaling pathways (Src and AKT/PI3K) leading to retinal angiogenesis.” The researchers concluded that present clinical research “consequently affirms the futuristic application of silver nanoparticles as a boon to ocular therapies.”